Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study

This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. Many of these complications may not be known for years after the treatment and preventive measures can be taken to reduce the chances that a complication will occur and encourage early detection. This study focuses on one complication that stem cell transplant survivors are at high risk of developing - skin cancer. An early diagnosis of skin cancer is important since the cancer is usually smaller, requires less extensive treatments, and has better outcomes. Teaching skin self-examination and encouraging patients to alert doctors to skin changes may provide an important opportunity for early detection of skin cancer.

Inclusion Criteria: * Have undergone autologous or allogeneic hematopoietic stem cell transplantation (HCT) at City of Hope (COH) * Are 2 years (yrs) to 5 yrs (+/- 3 months \[m\]) after HCT * Have seen a primary care provider (PCP) in the previous 12 m (expected \> 95% of all eligible) or planning to do so in next 12 m * Have a mobile phone with the ability to receive text messages * Can fluently read and write in English or Spanish * Can understand and sign the study-specific Informed Consent Form (ICF) Exclusion Criteria: * Patients who have evidence of active hematologic malignancy or acute illness that would limit study participation